Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

✍ Scribed by Harvey White; Claes Held; Ralph Stewart; David Watson; Robert Harrington; Andrzej Budaj; Ph. Gabriel Steg; Christopher P. Cannon; Susan Krug-Gourley; Janet Wittes; Trupti Trivedi; Elizabeth Tarka; Lars Wallentin

• Book ID: 116192235
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 341 KB
• Volume: 160
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2010.07.006